Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Mebhydrolin napadisylate
Cat. No.:
OB0225LY-0170
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Mebhydrolin napadisylate is a second-generation antihistamine that is primarily used to relieve allergy symptoms.
Synonym:
Incidal; Diazolin; Mebhydroline 1,5-naphthalenedisulfonate salt; Omeril; Diazoline; 6153-33-9
CAS No.:
6153-33-9
Formula:
C19H20N2·1/2C10H8O6S2
Formula Weight:
420.52
Specification
Relative Density:
0.9799 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Mebhydrolin napadisylate can be used to study the mechanisms of allergy or play an important role in immunological studies.
Library Information
Targets:
G protein-coupled receptors (GPCRs)
Receptors:
Histamine receptor; 5-HT receptor; mAChR
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
b3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM Water
Solubility:
Slightly soluble in DSMO.
